Grosen E A, Yamamoto R S, Ioli G, Ininns E K, Gatanaga M, Gatanaga T, DiSaia P J, Berman M, Manetta A, Granger G A
Department of Obstetrics and Gynecology, University of California Irvine 92717-3900.
Lymphokine Cytokine Res. 1992 Dec;11(6):347-53.
Studies were conducted to identify and establish the cell and tissue source of blocking factors (BF), materials that inhibit the bioactivity of human TNF and LT in vitro. Ascites and samples of solid tumors were collected from women with various gynecologic malignancies. Supernatants were collected from cultures of tumor and ascites cells after 24, 48, and 72 h. Cell-free ascites (CFA) and culture supernatants were tested for their ability to block human recombinant TNF and LT-induced lysis of L929 cells in vitro. Levels of soluble forms of the 55- and 75-kDa TNF/LT receptors were measured by ELISA assay in the same samples. CFA and culture supernatants contained TNF/LT blocking factors and high levels of one or both soluble 55- and 75-kDa TNF/LT membrane receptors. Levels of BF bioactivity and receptors appeared rapidly, peaked at 24 h, and declined thereafter. Soluble TNF/LT receptors may be the active BF in these samples, and tumor tissues and ascitic cells may be a source of these receptors in the ascites fluid of these patients.
开展了多项研究以鉴定并确定阻断因子(BF)的细胞和组织来源,阻断因子是在体外抑制人肿瘤坏死因子(TNF)和淋巴毒素(LT)生物活性的物质。从患有各种妇科恶性肿瘤的女性身上收集腹水和实体瘤样本。在培养24、48和72小时后,从肿瘤细胞和腹水细胞培养物中收集上清液。检测无细胞腹水(CFA)和培养上清液在体外阻断人重组TNF和LT诱导的L929细胞裂解的能力。通过酶联免疫吸附测定(ELISA)法测量相同样本中55 kDa和75 kDa TNF/LT受体可溶性形式的水平。CFA和培养上清液含有TNF/LT阻断因子以及高水平的一种或两种可溶性55 kDa和75 kDa TNF/LT膜受体。BF生物活性和受体水平迅速出现,在24小时达到峰值,随后下降。可溶性TNF/LT受体可能是这些样本中的活性BF,肿瘤组织和腹水细胞可能是这些患者腹水中这些受体的来源。